Some interesting points to consider if you need medical evaluation.
Clinical Chemistry
Transgender Man Being Evaluated for a Kidney Transplant
Cameron T. Whitley, Dina N. Greene
DOI: 10.1373/clinchem.2016.268839 Published October 2017
<
http://clinchem.aaccjnls.org/content/63/11/1680>
Key Points.
A 33-year-old female-to-male transgender individual presented to emergency care with acute otitis media and hypertension.
In the patient's medical chart, only the corresponding male eGFR was documented, and the medical care team did not consider that the sex-based equations will lead to a different interpretation.
Sex-specific cutoffs are often used to diagnose, monitor, and define treatment strategies. However, virtually no studies have determined reference intervals appropriate for transgender patients. There are few areas where sex-specific recommendations are more concrete than kidney function, but a literature search for "transgender and kidney disease" resulted in no applicable publications.
The patient's kidney disease etiology was unrelated to his transgender identity, it was attributed to him having Kawasaki's disease as a toddler. The early suggestions to immediately stop testosterone treatment and comments documented in the medical chart such as "but this man has a uterus," underline the lack of awareness around the transgender state and the care team's inaccurate assumptions about gender dysphoria therapy.
This (case) highlights a broader need for transgender education within medical communities. There are at least 1.4 million transgender people in the US. Kidney disease impacts >10% of adults, meaning that there are approximately 140000 transgender people who may not be receiving adequate care on the basis of current medical recommendations that adhere to sex-specific parameters.
